Page 49 - Protein Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

A recorded rebroadcast will be available for interested parties unable to participate in the live conference call by dialing 1-844-512-2921 or 1-412-317-6671 (for international callers) and referencing Conference ID 13718437. The replay will be available from 11:00 a.m. CDT on Thursday, May 6, 2021 until 11:00 p.m. CDT on Sunday, June 6, 2021. Bio-Techne Corporation (NASDAQ: TECH) is a leading developer and manufacturer of high-quality purified proteins and reagent solutions - notably cytokines and growth factors, antibodies, immunoassays, biologically active small molecule compounds, tissue ...

(2) Robust preclinical data support the benefit of PRX005, a novel anti-tau antibody, for the potential treatment Alzheimer's disease New pre-specified exploratory subgroup analyses and new digital biomarker data from Part 1 of the Phase 2 PASADENA study of prasinezumab in patients with early Parkinson's disease will be featured in two separate presentations DUBLIN, Ireland, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical company with expertise in protein dysregulation and a pipeline of investigational therapeutics for rare peripheral amyloid...

Stamford firm joins CT biotech companies growing amid pandemic FacebookTwitterEmailLinkedInRedditPinterest Photo: Matthew Brown / Hearst Connecticut Media About four years ago, a nascent health care information firm was spun out of the Mount Sinai Health System into a new company. Today, that business is worth approximately $2 billion and about to become a publicly traded enterprise. The rise of the Stamford-headquartered Sema4 attests to the potential of Connecticut’s biotechnology sector. Powered by large-scale investment, Sema4 and other companies in the industry are growing quickly and ...

Technavio Research: $4.02 Billion Growth in Liquid Biopsy Market During 2020-2024 | Featuring ANGLE Plc and Biocept Inc. Among Others | Technavio This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210204005734/en/ Technavio has announced its latest market research report titled Global Liquid Biopsy Market 2020-2024 (Graphic: Business Wire) Amid the COVID-19 pandemic the global liquid biopsy market registered a YOY growth of 30.45% in 2020 and the market is estimated to expand at a CAGR of almost 38% during the forecast period. The repo...

Share this article Share this article MINNEAPOLIS, Feb. 2, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the second quarter ended December 31, 2020. Second Quarter FY2021 Snapshot Second quarter organic revenue increased by 19% (21% reported) to $224.3 million and 15% (16% reported) in the first half of fiscal 2021 to $428.5 million.   GAAP EPS was $1.15 versus $3.02 one year ago primarily relating to a non-recurring gain of approximately $121 million in our ChemoCentryx investment in the second quarter of fiscal 2020. Delivered record a...